Skip to main content
Article
Discussion: Managing Risk When Using Idelalisib.
Clinical advances in hematology & oncology (2016)
  • Steven E. Coutre, Stanford University
  • Jan A. Burger, Georgetown University
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Disciplines
Publication Date
January 1, 2016
Citation Information
Steven E. Coutre, Jan A. Burger and John M. Pagel. "Discussion: Managing Risk When Using Idelalisib." Clinical advances in hematology & oncology Vol. 14 Iss. 5 (2016) p. 13 - 14
Available at: http://works.bepress.com/john-pagel/45/